Recent News

• 03.11.2025 - Better Choice Company Signs Binding Letter of Intent to Acquire Choice Specialty Pharmacy, Expanding U.S. Presence
• 03.07.2025 - Better Choice Company to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 27th at 4:30 p.m. ET
• 03.04.2025 - Better Choice Company Appoints Renowned Expert in Rare and Undiagnosed Diseases, Dr. Paldeep S. Atwal, as its United States Special Healthcare Advisor
• 02.28.2025 - SRx Health Solutions Granted Final Order to Proceed with the Acquisition by Better Choice Company
• 02.24.2025 - SRx Health Solutions Shareholders Unanimously Approve Acquisition by Better Choice Company
• 02.20.2025 - Better Choice Company Agrees in Principle to Licensing Agreement in Asia for its Halo Elevate® Brand
• 02.19.2025 - Better Choice Company Adjourns Special Meeting of Stockholders to March 21, 2025
• 02.19.2025 - Better Choice Company Signs Definitive Agreement to Sell Halo Asia for $8.1 Million in Total Gross Proceeds
• 01.28.2025 - Better Choice Company Signs Non-Binding Term Sheet to Sell Halo Asia for $6.5 Million in Cash at Closing and a 5-Year Royalty Valued at a Minimum of $1.65 Million
• 12.17.2024 - Better Choice Company Provides Shareholder Update Regarding its Authorized Stock Repurchase Program

Recent Filings

• 03.07.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 02.20.2025 - 8-K Current report
• 02.20.2025 - EX-99.1 EX-99.1
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.28.2025 - 8-K Current report
• 01.28.2025 - DEF 14A Other definitive proxy statements
• 01.06.2025 - PREM14A Preliminary proxy statements relating to merger or acquisition
• 12.26.2024 - PRE 14A Other preliminary proxy statements
• 12.26.2024 - 4 Statement of changes in beneficial ownership of securities
• 12.20.2024 - 8-K Current report